Réf. : HematoStat.net ; 3 (1) : R50 Harrison CN, Garcia JS, Somervaille TCP, Foran JM, Verstovsek S, Jamieson C, et al. Addition of Navitoclax to Ongoing Ruxolitinib Therapy for [...]

Réf. : HematoStat.net ; 3 (1) : R49 Wu Y-J, Liu H, Zeng Q-Z, Liu Y, Wang J-W, Wang W-S, et al. All-trans retinoic acid plus low-dose rituximab vs low-dose [...]